Mutations in the Wilms’ tumor gene, WT1, can lead to syndromic steroid-resistant nephrotic syndrome and isolated steroid-resistant nephrotic syndrome. WT1 mutations have been identified in the majority ... children with…
Therefore, it is necessary to look for a biomaterial that permits shielding of WT1-5 oncolytic rotavirus in order to elude the antibody recognition and reach the tumor satisfactorily ... platelets as potential oncolytic…
young adults. This tumor is characterized by the presence of a specific EWS-WT1 fusion gene, which is the result of recurrent chromosomal translocation ... terminal domain that mediates potent transcriptional activation…
Introduction. The WilmsâÂ?Â? tumor 1 gene (WT1) is related to several hematopoietic malignancies, including acute myeloid leukemia (AML) [1]. It encodes a 49-52 kDa protein with both oncosuppressor ... oncogene roles…
Wilms? tumor 1 (WT1) gene located at chromosome 11p13 normally provides instructions for the synthesis of a protein which is involved in the development of the urogenital system. Initially this ... discovered as a…
Wilms? tumor 1 (WT1) gene located at chromosome 11p13 normally provides instructions for the synthesis of a protein which is involved in the development of the urogenital system. Initially this ... discovered as a…
Therefore, it is necessary to look for a biomaterial that permits shielding of WT1-5 oncolytic rotavirus in order to elude the antibody recognition and reach the tumor satisfactorily ... platelets as potential oncolytic…
with de novo childhood acute lymphoblastic leukemia (ALL) and 19 adult patients with ALL. WT1 mRNA showed high positive expression rates of 90% or more in ALL patients, and fusion ... childhood ALL cases prior to…
effected by race sociocultural differences and interethnic group. Mutations in NPHS2 and WT1 genes record for nearly 20% and 5% of all children cases with steroid-resistant nephrotic syndrome, respectively…
anti-CD3 along with HLA-A*0201 fused to WilmsâÂ?Â? tumor 1 (WT1) peptide epitope were designed for the treatment of EGFR-related cancers utilizing various computational approaches ... this strategy in cancer treatment…
tumor cells. In present work, acute lymphocytic leukemia REH cells was infected with adapted Wt1-5 Rotavirus previously reported. Infection produced by active oncolytic Rotavirus induced expression of cell death…
Mutations in the Wilms' tumor suppressor gene (WT1) can lead to syndromic forms of steroid-resistant nephrotic syndrome (SRNS) such as Denys-Drash or Frasier syndrome and can cause isolated ... SRNS. A mutation within…
Wilms’ tumor suppressor gene 1 (WT1) mutations are found in Denys-Drash syndrome, Frasier syndrome and isolated diffuse mesangial sclerosis; these mutations lead to the occurrence of diffuse mesangial sclerosis…
induction of an efficient immune response against tumor-associated antigens. Wilms’ tumor 1 (WT1) shown to be the most potent tumor-associated antigens may have potentially strong therapeutic activity against…
Overexpression of the Wilms tumor 1 gene (WT1) is implicated in the prognosis of acute myeloid leukemia (AML) with high expression predicting disease progression, as well as being intensively studied ... molecular…
therapies are principally attributed to the presence of tumor-associated antigens. Wilms tumor 1 (WT1), an attractive target antigen widely expressed in every cancer, sarcoma, and leukemia, has been shown…
vaccinations pulsed with human leukocyte antigen (HLA)-Class I/II-restricted Wilms’ tumor 1 (WT1) peptides during chemoradiotherapy. The induction of WT1 antigen-specific cytotoxic T cells (WT1 ... markedly increased by…
ring chromosomes, translocation and numerical (monosomy, trisomy) variations. Further, we evaluated the frequency of WT1/WT2 gene mutation in cases and controls. PCR based analysis demonstrated that the frequency…
focus on the rationales underlying our ongoing clinical trial to test the efficacy of WT1 peptide based immunotherapy using TLR3 agonist as adjuvant in combination of the depletion
Also our study has contributed to the descriptions of previously known pathogenic mutations across WT1 (R205C) and SMARCAL1 (R764Q) and a novel polymorphism in CRB2. Conclusion:In summary, this ... SRNS. For the first…
cells (EPDCs) and the engrafted MSCs towards cardiomyocytes and vascular cells was examined by Wt1 immunostaining and Flag labeling. In transgenic mouse models, the activated EPDCs expressed GFP. At four ... infarcted…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.